Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Mayo Clinic: Mammogram rates dropped after controversial federal recommendation
The controversial U.S. Preventive Services Task Force recommendation that women under 50 reconsider routine mammograms may have caused a slide in screening rates.
2. Boston Scientific sells Prolieve device back to Medifocus for $5M
Boston Scientific sells the Prolieve benign prostatic hyperplasia treatment system back to Medifocus in a deal worth up to $5 million.
1. FDA chides Covidien on handling of surgical staple recall
The FDA warns Covidien on missing documentation and delayed management of its recall of the Duet TRS surgical staples that were implicated in 13 patient injuries and 3 deaths.